恶液质新药Adlumiz在国内能买到吗？

Adlumiz (anamorelin) is used to treat cancer cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, colorectal cancer and other malignancies. Cancer cachexia is a complex syndrome of metabolic disorders characterized by weight loss, particularly muscle mass, and cancer-related anorexia. It is understood that before the approval of Adlumiz (anamorelin), no effective drug for the treatment of cancer cachexia had been approved. As the first drug to treat cancer cachexia, the approval of Adlumiz (anamorelin) is an important milestone and one of the most important innovations in oncology. Adlumiz (anamorelin) can improve patients' quality of life, and (anamorelin) can significantly increase weight, improve muscle mass, and increase appetite. Is the new cachexia drug Adlumiz available in the country?

Currently, Adlumiz (anamorelin) is not marketed in China, so patients cannot purchase the drug in domestic pharmacies. If patients want to know the specific price information of Adlumiz (anamorelin), or want to purchase Adlumiz (anamorelin) with a high cost performance, they can consult with domestic reliable overseas medical service companies (such as Medical Companion Travel).

Adlumiz (anamorelin) Precautions

Hyperglycemia may occur during treatment with Adlumiz (anamorelin), so blood glucose levels and urine glucose should be measured regularly before and during treatment with Adlumiz (anamorelin).

Treatment with Adlumiz (anamorelin) may result in liver dysfunction, so liver function tests should be performed before and periodically during treatment with Adlumiz (anamorelin).

Adlumiz (anamorelin) should not be used in patients who are allergic to any of its components.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: